AI to transform all processes in drug development by 2026, predicts CPHI Report

In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs

PrecisionLife announces strategic CNS drug development collaboration with Nanopharmaceutics

Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio

Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology

Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging

Enveric Biosciences advances drug development for mental health indications

Advancing to IND-enabling studies with multiple drug candidates

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia

AWS partners with Pfizer to accelerate drug development

It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies

AIkido updates on use of machine learning in drug development orogram

The goal for the project is the identification and optimization of anti-viral compounds.

Orionis expands Novartis partnership in potential $1.4 billion molecular glue drug feal

ZoBio launches DEL platform to accelerate drug discovery for challenging targets

New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography

Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers

Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise